Lanthanide Complexes with Phenylethynylpyridine Chromophores

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing lanthanide complexes used for labeling molecules and detecting biological interactions face issues with brightness, solubility in aqueous media, and compatibility with laser excitation wavelengths, particularly at 337 nm, and lack stability in biological environments.

Innovation Solution

Development of complexing agents with trinitrogen macrocycles substituted by phenylethynylpyridine chromophores and optionally polyethylene glycol (PEG) groups, which form stable complexes with lanthanides, enhancing quantum efficiency, luminescence lifetime, and excitation spectrum alignment with 337 nm laser excitation, and incorporating reactive groups for biomolecule conjugation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Illumination intensity

If lanthanide complexes with phenylethynylpyridine chromophores and PEG groups are designed, then brightness and quantum efficiency are improved, but synthesis complexity increases

Engineering Contradiction:
ImprovebrightnessVSAvoidsynthesis complexity
Core Design Contradiction:
Illumination intensityVSDevice complexity

Solution Approach 1:

The complexing agent is divided into distinct functional modules: a trinitrogen macrocycle core (1,4,7-triazacyclononane ring), phenylethynylpyridine chromophore substituents attached to nitrogen atoms, and polyethylene glycol (PEG) side chains. This modular segmentation allows independent optimization of each component's properties while simplifying the overall synthesis pathway through standardized subunit assembly.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the complexing agent are assigned specific functional properties: the macrocycle core provides structural stability and lanthanide coordination, the phenylethynylpyridine chromophores localized on nitrogen atoms provide light absorption and energy transfer capabilities, and PEG groups provide aqueous solubility. This local quality differentiation enables simultaneous optimization of multiple performance parameters without compromising overall synthesis feasibility.

Inventive Principle:
Principle #3Local quality

2Adaptability or versatility

If complexes are designed for 337 nm laser excitation, then compatibility with biological assays is improved, but absorption optimization becomes more difficult

Engineering Contradiction:
Improvecompatibility with biological assaysVSAvoidabsorption optimization
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The absorption characteristics of the phenylethynylpyridine chromophores are optimized by adjusting molecular parameters such as the extent of conjugation, substituent positions, and electronic donor/acceptor groups. These parameter changes shift the absorption maximum toward 337 nm to match commercial laser wavelengths, enabling direct compatibility with standard biological assay equipment without requiring additional wavelength conversion components.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If reactive groups are incorporated for biomolecule conjugation, then ease of labeling is improved, but complex stability in aqueous media may decrease

Engineering Contradiction:
Improveease of labelingVSAvoidcomplex stability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The reactive group functionality is extracted as a separate, removable component attached via a spacer arm to the macrocycle structure. This allows the reactive group to be selectively introduced or removed without affecting the core lanthanide complex stability. The spacer arm acts as a buffer that isolates the reactive functionality from the coordination sphere, maintaining complex integrity while enabling bioconjugation when needed.

Inventive Principle:
Principle #2Taking out (Extraction)

4Quantity of substance

If PEG groups are added to improve solubility, then solubility in aqueous medium is improved, but molecular weight and complexity increase

Engineering Contradiction:
Improvesolubility in aqueous mediumVSAvoidmolecular weight
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The complexing agent employs a composite structure combining the hydrophobic trinitrogen macrocycle core with hydrophilic polyethylene glycol (PEG) side chains. This composite architecture creates an amphiphilic molecule where the PEG groups extend into the aqueous environment, providing solubility enhancement without requiring excessive molecular weight. The controlled length and positioning of PEG chains optimize the balance between solubility and molecular complexity.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new complexes exhibit improved brightness, stability, and solubility, enabling effective labeling and detection of biomolecules with enhanced photophysical properties suitable for FRET experiments and biological assays.

Implementation Method 1

the absorption of this complex is optimal at 315 nm, whereas the laser lamps often used in biological assays emit at the wavelength of 337 nm

Methodology Applied
Scientific EffectAbsorption (EM radiation): Absorption (EM radiation)

Implementation Method 2

lanthanide complexes have seen their use increase very significantly over the past twenty years in the field of life sciences. These fluorescent compounds indeed have interesting spectroscopic characteristics

Methodology Applied
Scientific EffectLuminescence: Luminescence

Implementation Method 3

The relatively long lifetime of lanthanide complexes also makes it possible to perform time-resolved fluorescence measurements, that is to say with a delay after excitation of the fluorophores

Methodology Applied
Scientific EffectTime-resolved fluorescence: Fluorescence

Implementation Method 4

complexing agents consisting of a trinitrogen macrocycle (1,4,7-triazacyclononane, hereafter 147TACN, 1,5,9-triazacyclododecane, hereafter 159TACD, 1,4,8-triazacyclodecane, hereinafter 148TACD or 1,4,8-triazacycloundecane, hereinafter 148TACU) whose nitrogen atoms are substituted by chromophores

Methodology Applied
Scientific EffectComplexation: Chemical Bonding

Data Source

PatentEP2734518B1Complexing agents and corresponding lanthanide complexes
Publication Date: 2016.04.27 CISBIO BIOASSAYS
  • EP2734518B1 patent drawingFigure 1
  • EP2734518B1 patent drawingFigure 2
  • EP2734518B1 patent drawing

AI summary

The aim of the present invention is to produce complexing agents of formula (I), in which a, b, c, Chrom1, Chrom2, Chrom3, R3, R4 and R5 are as defined in the description. The invention also concerns lanthanide complexes comprising said complexing agents, as well as a method for synthesising said agents.